WO2004101607A3 - Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh - Google Patents

Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh Download PDF

Info

Publication number
WO2004101607A3
WO2004101607A3 PCT/US2004/014932 US2004014932W WO2004101607A3 WO 2004101607 A3 WO2004101607 A3 WO 2004101607A3 US 2004014932 W US2004014932 W US 2004014932W WO 2004101607 A3 WO2004101607 A3 WO 2004101607A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
methodology
identification
positive cells
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/014932
Other languages
English (en)
Other versions
WO2004101607A2 (fr
Inventor
William H Hildebrand
Heather D Hickman-Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP04752061A priority Critical patent/EP1625151A2/fr
Publication of WO2004101607A2 publication Critical patent/WO2004101607A2/fr
Publication of WO2004101607A3 publication Critical patent/WO2004101607A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne de manière générale une méthodologie pour isoler, purifier et identifier des ligands peptidiques, présentés par les cellules positives du CMH. La méthodologie de la présente invention concerne notamment l'isolement, la purification et l'identification de ces ligands peptidiques à partir de molécules solubles de classe I et de classe II pouvant être issues de cellules non infectées, infectées ou tumorigènes. La méthodologie de la présente invention permet dans une large mesure à ces ligands peptidiques et à leurs protéines sources apparentées, d'être identifiés et utilisés comme marqueurs pour des cellules infectées par opposition à des cellules non infectées et/ou à des cellules tumorigènes par rapport à des cellules non tumorigènes, ladite identification étant utile pour marquer ou cibler une cellule en vue d'un traitement thérapeutique ou pour amorcer la réponse immunitaire à des cellules infectées.
PCT/US2004/014932 2003-05-13 2004-05-13 Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh Ceased WO2004101607A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04752061A EP1625151A2 (fr) 2003-05-13 2004-05-13 Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46999503P 2003-05-13 2003-05-13
US60/469,995 2003-05-13
US51813203P 2003-11-07 2003-11-07
US60/518,132 2003-11-07

Publications (2)

Publication Number Publication Date
WO2004101607A2 WO2004101607A2 (fr) 2004-11-25
WO2004101607A3 true WO2004101607A3 (fr) 2005-08-11

Family

ID=33457169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/014932 Ceased WO2004101607A2 (fr) 2003-05-13 2004-05-13 Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh

Country Status (2)

Country Link
EP (1) EP1625151A2 (fr)
WO (1) WO2004101607A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062512A1 (en) * 2000-10-10 2009-03-05 Hildebrand William H Comparative ligand mapping from MHC class I positive cells
WO2007030451A2 (fr) * 2005-09-07 2007-03-15 Receptor Logic, Ltd. Anticorps utilises comme mimetiques de recepteurs de lymphocytes t, leurs methodes de production et leurs applications
EP2740484A1 (fr) * 2012-12-05 2014-06-11 Lipotec, S.A. Compose utiles dans le traitement et/ou les soins de la peau, des muqueuses du cuir chevelu et/ou des cheveux et leur utilisation dans des compositions cosmétiques ou pharmaceutiques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086122A2 (fr) * 2001-03-14 2002-10-31 Hybrigenics Interactions proteine-proteine intensifiees dans des cellules adipeuses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086122A2 (fr) * 2001-03-14 2002-10-31 Hybrigenics Interactions proteine-proteine intensifiees dans des cellules adipeuses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EPO Proteins [online] 27 March 2003 (2003-03-27), "Sequence 1267 from Patent WO02086122.", XP002314962, retrieved from EBI accession no. EPOP:AX678488 Database accession no. AX678488 *
RAMMENSEE HANS-GEORG ET AL: "SYFPEITHI: Database for MHC ligands and peptide motifs", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 50, no. 3-4, November 1999 (1999-11-01), pages 213 - 219, XP002183663, ISSN: 0093-7711 *
SATHIAMURTHY M ET AL: "Population of the HLA ligand database.", TISSUE ANTIGENS, vol. 61, no. 1, January 2003 (2003-01-01), pages 12 - 19, XP002314961, ISSN: 0001-2815 *

Also Published As

Publication number Publication date
WO2004101607A2 (fr) 2004-11-25
EP1625151A2 (fr) 2006-02-15

Similar Documents

Publication Publication Date Title
WO2002030964A3 (fr) Mappage comparatif de ligand a partir de cellules positives cmh
WO2004060308A3 (fr) Thiosemicarbazones antiviraux et immunostimulants
DE602006019629D1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
WO2009147248A3 (fr) Séquences d'acides aminés dirigées contre des protéines d'enveloppe d'un virus, et polypeptides comprenant ces séquences destinés au traitement de maladies virales
WO2004080403A3 (fr) Vaccin contre le virus de la grippe
WO2004024757A3 (fr) Molecules pna modifiées
WO2008017826A3 (fr) Protéines immunogéniques et leurs utilisations
EA201001212A1 (ru) Лечение микробных инфекций
DE602005008996D1 (de) Radiofluorierte peptide
ATE458746T1 (de) Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
WO2010041241A3 (fr) Peptides dérivés de l'intégrase du vih-1 et compositions
WO2006062402A3 (fr) Hsp et arythmie supraventriculaire
WO2009037183A3 (fr) Préparation cosmétique et/ou pharmaceutique contenant des acides nucléiques destinée à la production de peptides antimicrobiens dans des tissus épithéliaux
WO2007019865A3 (fr) Traitement au moyen de peptides de liaison cd4 et par rayonnements
CL2008001719A1 (es) Compuestos derivados de [1,10]-fenantrolina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades neurodegenerativas o hematologicas.
ATE380557T1 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
WO2005023849A3 (fr) Peptides antigeniques du virus rabique et leurs utilisations
WO2004101607A3 (fr) Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh
WO2006137938A3 (fr) Fragments d'anticorps assurant la protection contre l'infection par des pathogenes, methodes d'utilisation de ces derniers
WO2007053644A3 (fr) Cartographie comparative des ligands de cellules positives vis-a-vis du mhc de classe i
WO2009077744A3 (fr) Vaccins contre la brucellose
WO2007076091A3 (fr) Traitement d’infections virales utilisant un inhibiteur de facteur tissulaire
WO2010046778A3 (fr) Nouveaux antigènes de protéines de shigella et méthodes
DK1537204T3 (da) Granzym B som HSP70/HSP70-peptidafhængig udløser af programmeret celledød hos tumorceller
WO2008045017A3 (fr) Inhibiteurs des virus sars et ebola, leur utilisation, et procédés pour les découvrir

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004752061

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004752061

Country of ref document: EP